Published in Antimicrob Agents Chemother on July 01, 1999
antiSMASH 2.0--a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res (2013) 8.10
The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother (2000) 2.71
Natural-product sugar biosynthesis and enzymatic glycodiversification. Angew Chem Int Ed Engl (2008) 2.69
Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell (2014) 2.59
Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc Natl Acad Sci U S A (2002) 1.57
A systematic computational analysis of biosynthetic gene cluster evolution: lessons for engineering biosynthesis. PLoS Comput Biol (2014) 1.54
Structure of the TDP-epi-vancosaminyltransferase GtfA from the chloroeremomycin biosynthetic pathway. Proc Natl Acad Sci U S A (2003) 1.45
Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides. Microbiol Mol Biol Rev (2006) 1.41
Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Mol Pharm (2008) 1.35
How nature morphs peptide scaffolds into antibiotics. Chembiochem (2009) 1.14
Tailoring enzyme-rich environmental DNA clones: a source of enzymes for generating libraries of unnatural natural products. J Am Chem Soc (2010) 1.03
Biosynthesis of chloro-beta-hydroxytyrosine, a nonproteinogenic amino acid of the peptidic backbone of glycopeptide antibiotics. J Bacteriol (2004) 1.03
Avoidance of suicide in antibiotic-producing microbes. J Ind Microbiol Biotechnol (2010) 1.01
What's new in enzymatic halogenations. Curr Opin Chem Biol (2007) 0.98
Genomic mining for novel FADH₂-dependent halogenases in marine sponge-associated microbial consortia. Mar Biotechnol (NY) (2012) 0.97
Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis. BMC Genomics (2014) 0.95
Characterization of a regiospecific epivancosaminyl transferase GtfA and enzymatic reconstitution of the antibiotic chloroeremomycin. Proc Natl Acad Sci U S A (2004) 0.90
Detection, distribution, and organohalogen compound discovery implications of the reduced flavin adenine dinucleotide-dependent halogenase gene in major filamentous actinomycete taxonomic groups. Appl Environ Microbiol (2009) 0.89
Heterologous expression in Escherichia coli of the first module of the nonribosomal peptide synthetase for chloroeremomycin, a vancomycin-type glycopeptide antibiotic. Proc Natl Acad Sci U S A (2000) 0.85
Genome mining reveals the genus Xanthomonas to be a promising reservoir for new bioactive non-ribosomally synthesized peptides. BMC Genomics (2013) 0.84
Structural characterization of OxyD, a cytochrome P450 involved in beta-hydroxytyrosine formation in vancomycin biosynthesis. J Biol Chem (2010) 0.84
Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926. J Bacteriol (2007) 0.83
Brominated skeletal components of the marine demosponges, Aplysina cavernicola and Ianthella basta: analytical and biochemical investigations. Mar Drugs (2013) 0.83
Cloning, sequencing, and functional analysis of an iterative type I polyketide synthase gene cluster for biosynthesis of the antitumor chlorinated polyenone neocarzilin in "Streptomyces carzinostaticus". Antimicrob Agents Chemother (2004) 0.82
Understanding and manipulating glycopeptide pathways: the example of the dalbavancin precursor A40926. J Ind Microbiol Biotechnol (2006) 0.82
Differential proteomic analysis highlights metabolic strategies associated with balhimycin production in Amycolatopsis balhimycina chemostat cultivations. Microb Cell Fact (2010) 0.81
Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis. Proteins (2011) 0.80
Overproduction of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17. Antimicrob Agents Chemother (2014) 0.80
Bioprospecting potential of halogenases from Arctic marine actinomycetes. BMC Microbiol (2016) 0.78
Phylogenetic analysis of antibiotic glycosyltransferases. J Mol Evol (2007) 0.78
A Streptomyces coelicolor host for the heterologous expression of Type III polyketide synthase genes. Microb Cell Fact (2015) 0.77
Ketoolivosyl-tetracenomycin C: a new ketosugar bearing tetracenomycin reveals new insight into the substrate flexibility of glycosyltransferase ElmGT. Bioorg Med Chem Lett (2012) 0.75
The VanRS Homologous Two-Component System VnlRSAb of the Glycopeptide Producer Amycolatopsis balhimycina Activates Transcription of the vanHAXSc Genes in Streptomyces coelicolor, but not in A. balhimycina. Microb Drug Resist (2016) 0.75
Halogenation of glycopeptide antibiotics occurs at the amino acid level during non-ribosomal peptide synthesis. Chem Sci (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
Identification of protein coding regions by database similarity search. Nat Genet (1993) 21.58
Codon preference and its use in identifying protein coding regions in long DNA sequences. Nucleic Acids Res (1982) 9.99
Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene (1992) 9.83
Prediction of the occurrence of the ADP-binding beta alpha beta-fold in proteins, using an amino acid sequence fingerprint. J Mol Biol (1986) 9.13
Compilation and analysis of DNA sequences associated with apparent streptomycete promoters. Nucleic Acids Res (1992) 4.95
Codon usage in the G+C-rich Streptomyces genome. Gene (1992) 3.11
Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol (1996) 2.84
Rubredoxin reductase of Pseudomonas oleovorans. Structural relationship to other flavoprotein oxidoreductases based on one NAD and two FAD fingerprints. J Mol Biol (1990) 2.21
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem Biol (1998) 2.02
Structure-activity relationships of vancomycin-type glycopeptide antibiotics. J Antibiot (Tokyo) (1993) 1.79
Genetic analysis of erythromycin production in Streptomyces erythreus. J Bacteriol (1985) 1.76
Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrob Agents Chemother (1996) 1.68
Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production. Microbiology (1997) 1.63
Functions encoded by pyrrolnitrin biosynthetic genes from Pseudomonas fluorescens. J Bacteriol (1998) 1.54
Occurrence and biological function of cytochrome P450 monooxygenases in the actinomycetes. Mol Microbiol (1991) 1.41
An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea. Science (1991) 1.39
Organisation of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus: analysis of genes flanking the polyketide synthase. Gene (1996) 1.34
Identification of a Saccharopolyspora erythraea gene required for the final hydroxylation step in erythromycin biosynthesis. J Bacteriol (1993) 1.33
Genetics of streptomycin production in Streptomyces griseus: molecular structure and putative function of genes strELMB2N. Mol Gen Genet (1991) 1.28
Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis. Chem Biol (1997) 1.19
Cloning of an avilamycin biosynthetic gene cluster from Streptomyces viridochromogenes Tü57. J Bacteriol (1997) 1.14
The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis. J Bacteriol (1998) 1.13
Characterization and expression of a P-450-like mycinamicin biosynthesis gene using a novel Micromonospora-Escherichia coli shuttle cosmid vector. Mol Gen Genet (1994) 1.07
Efficient transformation of Amycolatopsis orientalis (Nocardia orientalis) protoplasts by Streptomyces plasmids. J Bacteriol (1987) 1.05
Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity. J Antibiot (Tokyo) (1994) 1.05
Cloning and analysis of a peptide synthetase gene of the balhimycin producer Amycolatopsis mediterranei DSM5908 and development of a gene disruption/replacement system. J Biotechnol (1997) 1.03
A gene cloning system for 'Streptomyces toyocaensis'. Microbiology (1996) 0.94
Triple hydroxylation of tetracenomycin A2 to tetracenomycin C in Streptomyces glaucescens. Overexpression of the tcmG gene in Streptomyces lividans and characterization of the tetracenomycin A2 oxygenase. J Biol Chem (1994) 0.90
Nucleotide sequence, transcriptional analysis, and glucose regulation of the phenoxazinone synthase gene (phsA) from Streptomyces antibioticus. J Bacteriol (1995) 0.88
New 4-oxovancosamine-containing glycopeptide antibiotics from Amycolatopsis sp. Y-86,21022. J Antibiot (Tokyo) (1996) 0.83
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature (1988) 4.41
Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem (1998) 3.80
Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg (2003) 2.96
Exact prediction of a natural T cell epitope. Eur J Immunol (1991) 2.90
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J (1994) 2.86
Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol (1996) 2.70
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med (1991) 2.48
Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol (1990) 2.37
Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med (1997) 2.33
Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem (1988) 2.32
Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett (1999) 2.16
Maltophilin: a new antifungal compound produced by Stenotrophomonas maltophilia R3089. J Antibiot (Tokyo) (1996) 2.07
Role of vascular endothelial-cadherin in vascular morphogenesis. Development (1999) 2.06
Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem (1986) 2.04
Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg (1984) 1.99
Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett (1998) 1.96
Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident. Int Arch Occup Environ Health (1990) 1.93
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A (1997) 1.84
Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 1.81
Characterization of Cd, Zn-thionein (metallothionein) isolated from rat and chicken liver. Eur J Biochem (1973) 1.79
Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A (1993) 1.77
Genome analysis of Bacillus amyloliquefaciens FZB42 reveals its potential for biocontrol of plant pathogens. J Biotechnol (2008) 1.73
Identification of Trk binding sites for SHC and phosphatidylinositol 3'-kinase and formation of a multimeric signaling complex. J Biol Chem (1993) 1.73
Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med (1995) 1.73
CLUSEAN: a computer-based framework for the automated analysis of bacterial secondary metabolite biosynthetic gene clusters. J Biotechnol (2009) 1.73
Expression of the Bacillus subtilis sacB gene leads to sucrose sensitivity in the gram-positive bacterium Corynebacterium glutamicum but not in Streptomyces lividans. J Bacteriol (1992) 1.68
Fengycin--a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo) (1986) 1.64
Melittin and a chemically modified trichotoxin form alamethicin-type multi-state pores. Biochim Biophys Acta (1983) 1.63
New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol (1996) 1.61
Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene (2006) 1.59
Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity (1995) 1.59
Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics (1994) 1.58
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene (2011) 1.57
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Characterization of a shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect Immun (2000) 1.53
Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett (1989) 1.53
Gene disruption and gene replacement in Streptomyces via single stranded DNA transformation of integration vectors. Nucleic Acids Res (1991) 1.53
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol (2000) 1.53
Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc Natl Acad Sci U S A (1997) 1.53
Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology (1988) 1.51
Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur J Immunol (1991) 1.51
Isolation and characterization of staphyloferrin A, a compound with siderophore activity from Staphylococcus hyicus DSM 20459. FEMS Microbiol Lett (1990) 1.49
Industrial applications of nanoparticles. Chem Soc Rev (2015) 1.49
Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J Immunol (1985) 1.46
The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood (1999) 1.45
Staphyloferrin A: a structurally new siderophore from staphylococci. Eur J Biochem (1990) 1.45
Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction. Ophthalmology (2000) 1.44
Two transcriptional regulators GlnR and GlnRII are involved in regulation of nitrogen metabolism in Streptomyces coelicolor A3(2). Mol Microbiol (2002) 1.44
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol (1996) 1.43
An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics (2000) 1.42
Myosin IB null mutants of Dictyostelium exhibit abnormalities in motility. Cell Motil Cytoskeleton (1991) 1.42
Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol (1990) 1.41
Primary colonic lymphoma. J Surg Oncol (2000) 1.40
In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem (1994) 1.40
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal Biochem (1994) 1.40
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur J Immunol (1999) 1.38
Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun (1998) 1.38
Evolution of the glutamine synthetase gene, one of the oldest existing and functioning genes. Proc Natl Acad Sci U S A (1993) 1.38
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab (2001) 1.37
Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med (1995) 1.37
Molecular characterization of lantibiotic-synthesizing enzyme EpiD reveals a function for bacterial Dfp proteins in coenzyme A biosynthesis. J Biol Chem (2000) 1.36
Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol (2000) 1.33
High-performance liquid chromatography of siderophores from fungi. Biol Met (1988) 1.32
Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem (1995) 1.32
On the transport of tripeptide antibiotics in bacteria. Eur J Biochem (1976) 1.31
Conformational changes of alamethicin induced by solvent and temperature. A 13C-NMR and circular-dichroism study. Eur J Biochem (1975) 1.31
Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1. J Mol Biol (1993) 1.31
Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals (1993) 1.31
Functions of unconventional myosins. Curr Opin Cell Biol (2000) 1.31
Assessment of intracranial hemodynamics in carotid artery disease by transcranial Doppler ultrasound. J Neurosurg (1985) 1.30
[Dissociation equilibrium of glutathione. A Fourier transform-13C-NMR spectroscopic study of pH-dependence and of charge densities]. Eur J Biochem (1972) 1.30
Ornibactins--a new family of siderophores from Pseudomonas. Biometals (1993) 1.30
Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem (1998) 1.30
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29
Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J Mol Biol (1994) 1.29
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28
Isolation and biological characterization of staphyloferrin B, a compound with siderophore activity from staphylococci. FEMS Microbiol Lett (1994) 1.28
Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe Seylers Z Physiol Chem (1983) 1.26
Identification of receptor binding sites by competitive peptide mapping: phages T1, T5, and phi 80 and colicin M bind to the gating loop of FhuA. J Bacteriol (1995) 1.26
Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol (1993) 1.26
Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic. Eur J Biochem (1991) 1.26
Mortality event in freshwater drum Aplodinotus grunniens from Lake Ontario, Canada, associated with viral haemorrhagic septicemia virus, type IV. Dis Aquat Organ (2007) 1.25
Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J Pept Sci (2001) 1.25
Tyrosine 785 is a major determinant of Trk--substrate interaction. EMBO J (1993) 1.25
Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of the cerebral arteries. Angiographic determination in man. Invest Radiol (1967) 1.25
Cranial nerve palsies in spontaneous carotid artery dissection. J Neurol Neurosurg Psychiatry (1993) 1.25